Otolaryngology · La Mesa, CA
NPI
1770673238
Since 2006
Specialty
Otolaryngology
Code 207Y00000X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
5565 Grossmont Center Drive, Building 3 Suite 101
La Mesa, CA, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$161K
2,042 services
Medicare patients, 2024
363
Average age 74
Drug cost, 2024
$147K
1,286 prescriptions
Company payments, 2025
$150K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Geoffrey B Pitzer was code 31231 (nasal/sinus endoscopy), 398 times for 253 patients. In total Geoffrey B Pitzer billed 2,042 services in 43 codes, and Medicare paid $161K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 31231 Nasal/Sinus Endoscopy | Office | 398 | 253 | $159.11 | $63K |
| 99214 Office E&M - Established | Office | 359 | 211 | $101.99 | $37K |
| 99204 Office E&M - New | Office | 144 | 144 | $121.67 | $18K |
| 69210 Other Organ Systems | Office | 128 | 103 | $27.43 | $3,511 |
| 92567 Test - Miscellaneous | Office | 127 | 121 | $13.74 | $1,745 |
| 92557 Vision, Hearing, and Speech Services | Office | 126 | 119 | $29.95 | $3,774 |
| 99213 Office E&M - Established | Office | 83 | 60 | $65.69 | $5,452 |
| G0268 Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 48 | 48 | $31.80 | $1,526 |
| 99442 Telephone Services | Office | 26 | 22 | $57.06 | $1,483 |
| 99203 Office E&M - New | Office | 19 | 19 | $79.56 | $1,512 |
| 69420 Other Organ Systems | Office | 18 | 13 | $160.33 | $2,886 |
By year: 2022 $126K for 1,207 services; 2023 $163K for 1,588 services; 2024 $161K for 2,042 services.
Medicare prescription drug claims, 2024
In 2024, the drug Geoffrey B Pitzer prescribed most often to Medicare patients was Azelastine Hcl, with 327 prescriptions and refills. In total Geoffrey B Pitzer wrote 1,286 Medicare prescriptions that cost $147K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 327 | 455 | 107 | $8,388 |
| Fluticasone Propionate Generic | 262 | 382 | 92 | $2,926 |
| Ipratropium Bromide Generic | 98 | 143 | 38 | $2,877 |
| Famotidine Generic | 87 | 189 | 38 | $750 |
| Omeprazole Generic | 78 | 177 | 47 | $1,230 |
| Pantoprazole Sodium Generic | 57 | 91 | 19 | $282 |
| Xhance Fluticasone Propionate | 45 | 46 | 14 | $50K |
| Ciprofloxacin-Dexamethasone Ciprofloxacin Hcl/Dexameth | 44 | 44 | 31 | $4,900 |
| Mupirocin Generic | 27 | 27 | 21 | $219 |
| Fluocinolone Acetonide Oil Generic | 25 | 28 | 13 | $813 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 25 | 25 | 12 | $342 |
| Doxycycline Monohydrate Generic | 24 | 24 | 17 | $557 |
| Prednisone Generic | 20 | 20 | 18 | $73.95 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 17 | 17 | 17 | $130 |
| Montelukast Sodium Generic | 16 | 27 | Under 11 | $213 |
Brand drugs: 93 claims; generic drugs: 1,193 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Geoffrey B Pitzer $150K ($3,225 in general payments such as food, travel and fees and $147K for research) from 18 companies. The largest payer was Sanofi US Services Inc. with $147K.
| Company | Payments | Amount |
|---|---|---|
| Sanofi US Services Inc. SNY | 17 | $147K |
| Optinose US, Inc. | 3 | $1,552 |
| Genzyme Corporation SNY | 10 | $532 |
| GlaxoSmithKline, LLC. GSK | 13 | $286 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $255 |
| Pfizer Inc. PFE | 2 | $110 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $93.79 |
| Resmed Corp RMD | 1 | $67.46 |
| Davol Inc. BDX | 3 | $62.62 |
| Smith+Nephew, Inc. SNN | 2 | $39.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.